Delivery Order SPE2DB22D9316-SPE2DB24FYM77
Award Date 11/27/23
Potential Completion Date 11/28/23
Potential Value $30K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at forty-five thousand six hundred sixty-five dollars and ninety-one cents ($45,665.91) by the Defense Logistics Agency Troop Support Medical to provide Cabometyx 40 mg tablets. The order was awarded on November 16, 2023 under the company's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand three hundred forty-six dollars and sixty-four cents ($30,346.64) by the Defense Logistics Agency Troop Support Medical to provide Cabometyx 60 mg tablets. The order was awarded on November 21, 2023 and is to be completed by November 22, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical products to the place of performance in Park Ridge, Illinois under the terms of the delivery...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against an indefinite delivery contract with the Defense Logistics Agency for $30,346.64 to supply Cabometyx 60 mg tablets. The delivery order requires DMS Pharmaceutical Group to provide 4562780637 units of Cabometyx 60 mg tablets, 30 tablets per unit, to Defense Logistics Agency Troop Support Medical by November 13, 2023. The indefinite delivery contract, with a potential value of up to $5 million through December...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand two hundred twenty-one dollars and ninety-seven cents ($15,221.97) by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide Cabometyx 40 mg tablets, 30 count per package. The place of performance is Park Ridge, Illinois and the completion date is November 14, 2023. DMS Pharmaceutical Group Inc. will fulfill this requirement as the prime contractor. No...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $15,173.31 by the Defense Logistics Agency Troop Support Medical to provide Cabometyx 60 mg tablets. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025. Under the indefinite delivery contract, DMS Pharmaceutical Group supplies various pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $15,221.97 under an indefinite delivery contract with the Defense Logistics Agency to supply Cabometyx 40 mg tablets. As a woman-owned small business, DMS Pharmaceutical Group will deliver 30 tablets of Cabometyx to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical by November 9, 2023. DMS Pharmaceutical Group currently supplies pharmaceuticals and medical products in...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cabometyx 60 mg tablets. The $30,346.64 order calls for 30 tablets to be delivered by October 30, 2023 to the Park Ridge, Illinois location. No set-aside designation was used for this order issued against DMS Pharmaceutical Group's existing pharmaceutical prime vendor contract vehicle with the DLA, which has a potential value of up...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifteen thousand three hundred ten dollars and eighty-three cents ($15,310.83) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
- DMS Pharmaceutical Group Inc. was awarded a $30,346.64 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply Cabometyx 60 mg tablets. The order is for 30 tablets and delivery is required by October 11, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical commodities. No set-aside provision was applied to this order, which will be fulfilled from DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand four hundred forty-three dollars and ninety-four cents ($30,443.94) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against the prime vendor's existing indefinite delivery contract to supply pharmaceutical items and medical products with a potential value of up to five million dollars through December 2025. Under this particular order, DMS...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYM77Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand three hundred forty-six dollars and sixty-four cents ($30,346.64) by the Defense Logistics Agency to provide Cabometyx 60 mg tablets. The order was awarded on November 27, 2023 and is to be completed by November 28, 2023. DMS Pharmaceutical Group will supply the pharmaceutical items to the Defense Logistics Agency under an existing indefinite delivery contract with no set-aside designation used on this order. The contract provides pharmaceuticals and medical supplies to support military treatment facilities globally with a potential value of up to five million dollars through December 2025.
Generated 2/26/24, 9:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.3k | 11/27/23 |